雌激素影响绝经后骨质疏松分子机制研究进展

被引:69
作者
孙伟明 [1 ]
刘爽 [2 ]
机构
[1] 天津中医药大学
[2] 天津中医药大学第二附属医院
关键词
雌激素; 绝经后骨质疏松; 破骨细胞; 成骨细胞;
D O I
暂无
中图分类号
R580 [];
学科分类号
摘要
<正>骨质疏松是以骨量减少、骨的微观结构退化为特征的,致使骨的脆性增加以及易于发生骨折的一种全身性骨骼疾病,可分为三大类即原发性骨质疏松、继发性骨质疏松、特发性骨质疏松。绝经后骨质疏松(PMOP)为Ⅰ型原发性骨质疏松,由绝经后机体雌激素水平下降而引发,年龄通常界定在50~70岁。雌激素的缺乏被认为是PMOP的主要原因,其中具体的分子机制仍未达成共识,本文结合近些年研究雌激素对PMOP发病机
引用
收藏
页码:499 / 502
页数:4
相关论文
共 17 条
[1]
ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways [J].
Yin, Xinhua ;
Wang, Xiaoyuan ;
Hu, Xiongke ;
Chen, Yong ;
Zeng, Kefeng ;
Zhang, Hongqi .
EXPERIMENTAL CELL RESEARCH, 2015, 335 (01) :107-114
[2]
Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation.[J].Qi Xiong;Peifu Tang;Yanpan Gao;Lihai Zhang;Wei Ge;Haiteng Deng.BioMed Research International.2015,
[3]
Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway [J].
Fan, Jin-Zhu ;
Yang, Liu ;
Meng, Guo-Lin ;
Lin, Yan-shui ;
Wei, Bo-Yuan ;
Fan, Jing ;
Hu, Hui-Min ;
Liu, Yan-Wu ;
Chen, Shi ;
Zhang, Jin-Kang ;
He, Qi-Zhen ;
Luo, Zhuo-Jing ;
Liu, Jian .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 392 (1-2) :85-93
[4]
Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone [J].
Song, Ruilong ;
Gu, Jianhong ;
Liu, Xuezhong ;
Zhu, Jiaqia ;
Wang, Qichao ;
Gao, Qian ;
Zhang, Jiaming ;
Cheng, Laiyang ;
Tong, Xishuai ;
Qi, Xinyi ;
Yuan, Yan ;
Liu, Zongping .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 (03) :856-862
[5]
Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study [J].
Eastell, Richard ;
Nagase, Shinichi ;
Small, Maria ;
Boonen, Steven ;
Spector, Tim ;
Ohyama, Michiyo ;
Kuwayama, Tomohiro ;
Deacon, Steve .
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (02) :458-466
[6]
Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER–ERK–mTOR pathway [J].
Yue-Hua Yang ;
Ke Chen ;
Bo Li ;
Jiang-Wei Chen ;
Xin-Feng Zheng ;
Yu-Ren Wang ;
Sheng-Dan Jiang ;
Lei-Sheng Jiang .
Apoptosis, 2013, 18 :1363-1375
[7]
HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis [J].
Miyauchi, Yoshiteru ;
Sato, Yuiko ;
Kobayashi, Tami ;
Yoshida, Shigeyuki ;
Mori, Tomoaki ;
Kanagawa, Hiroya ;
Katsuyama, Eri ;
Fujie, Atsuhiro ;
Hao, Wu ;
Miyamoto, Kana ;
Tando, Toshimi ;
Morioka, Hideo ;
Matsumoto, Morio ;
Chambon, Pierre ;
Johnson, Randall S. ;
Kato, Shigeaki ;
Toyama, Yoshiaki ;
Miyamoto, Takeshi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (41) :16568-16573
[8]
Estrogens Attenuate Oxidative Stress and the Differentiation and Apoptosis of Osteoblasts by DNA-Binding-Independent Actions of the ERα [J].
Almeida, Maria ;
Martin-Millan, Marta ;
Ambrogini, Elena ;
Bradsher, Robert, III ;
Han, Li ;
Chen, Xiao-Dong ;
Roberson, Paula K. ;
Weinstein, Robert S. ;
O'Brien, Charles A. ;
Jilka, Robert L. ;
Manolagas, Stavros C. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (04) :769-781
[9]
Purification and identification of estrogen receptor alpha co‐regulators in osteoclasts.[J].IchiroTakada;NaoyaTsuji;Min‐YoungYoun;SallyFujiyama;MaikoOkada;YuukiImai;ShinoKondo;HirochikaKitakawa;HisatakaYasuda;ShigeakiKato.Annals of the New York Academy of Sciences.2010, 1
[10]
Estrogen regulation of apoptosis in osteoblasts.[J].Peter G. Bradford;Ken V. Gerace;Renée L. Roland;Brian G. Chrzan.Physiology & Behavior.2009, 2